Targeted microbiology testing to identify infection-causing organisms and guide antibiotic therapy.
Healix360 supports access to advanced mobile wound care services for patients throughout our coverage area. Services are delivered by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds. Care is coordinated and provided directly to patients in private residences, assisted living communities, and skilled nursing facilities. Wound cultures work by sampling the deep wound tissue or fluid using a sterile collection technique, transporting the specimen to a clinical laboratory, and growing the organisms in a controlled medium. The lab then identifies the species and tests how susceptible each organism is to a panel of antibiotics, allowing clinicians to choose targeted therapy rather than empiric broad-spectrum antibiotics.
A licensed clinician determines whether this treatment is appropriate after evaluating the wound and the patient's medical history.
Treatment decisions are individualized. Potential contraindications and precautions may include:
After cleansing the wound with sterile saline, the clinician collects a small tissue sample or performs a quantitative swab from the deepest part of the wound bed. The specimen is sealed in a sterile transport medium and sent to the laboratory. Preliminary results are typically available within 24 to 48 hours, with full sensitivity reporting in 48 to 72 hours.
Infectious Diseases Society of America (IDSA) guidelines and the International Working Group on the Diabetic Foot recommend deep tissue cultures over superficial swabs for any wound suspected of clinical infection. Targeted antibiotic therapy guided by culture results consistently outperforms empiric broad-spectrum treatment for chronic wound infections.
Tissue sampling involves a brief, mild sensation in most patients. Topical anesthetic is applied if the wound bed has significant innervation. Most patients tolerate the collection without difficulty.
Preliminary identification is generally available within 24 to 48 hours, with complete antibiotic sensitivity reporting typically returning within 48 to 72 hours of collection.
Empiric broad-spectrum antibiotics can drive resistance, miss the actual pathogen, and expose patients to unnecessary side effects. Culture-guided therapy targets exactly what is present in the wound.
Standard cultures may underdetect biofilm-embedded organisms. When biofilm is suspected, clinicians may use molecular methods (such as PCR) or biopsy-based culture techniques that disrupt the biofilm before culturing.
Yes. Culture results, identified organisms, and recommended antibiotic therapy are documented in the visit note and shared with the primary care physician, attending facility staff, and any active home health agency.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.